Herzschrittmachertherapie und Elektrophysiologie最新文献_第7页

[Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future : Pros and cons]. [抗心律失常药物在未来治疗心房颤动中不再重要：利弊]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-13 DOI: 10.1007/s00399-024-01047-5

Andreas Metzner, Constanze Schmidt

{"title":"[Antiarrhythmic drugs will no longer be of importance in the treatment of atrial fibrillation in the future : Pros and cons].","authors":"Andreas Metzner, Constanze Schmidt","doi":"10.1007/s00399-024-01047-5","DOIUrl":"10.1007/s00399-024-01047-5","url":null,"abstract":"An early rhythm stabilization is the primary focus of the current treatment of atrial fibrillation. Based on current studies catheter ablation of pulmonary vein isolation (PVI) is an established component in the treatment of atrial fibrillation. Therefore, in the management of affected patients this procedure should be offered at an early stage in addition to the holistic treatment approach with consistent treatment of cardiovascular risk factors and thromboembolism prophylaxis with anticoagulants. Substances with an antiarrhythmic effect can be included in a supportive role in the management of atrial fibrillation. Pharmacotherapy could also perspectively play an important role in the treatment of the underlying atrial cardiomyopathy of the phenotype of atrial fibrillation. An understanding of the atrial pathophysiology of individual patients with adapted selection of suitable treatment strategies of ablation up to pharmacotherapy is decisive for the successful antiarrhythmic outcome. The decision on the treatment strategy must always be individually made together with the affected patient. The advantages and disadvantages of both options must be explained in detail and pre-existing comorbidities and risk factors must be included. Additionally, the individual wishes of the patient must be taken into account.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"274-281"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[My patients can go home in the evening after pulmonary vein isolation : Pros and cons]. [肺静脉隔离术后，我的病人晚上就能回家：利弊]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-11 DOI: 10.1007/s00399-024-01050-w

Burghard Schumacher, Suzanne de Waha, Roland R Tilz

引用次数: 0

[Conducted energy weapons (CEW)]. [导能武器（CEW）]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-11 DOI: 10.1007/s00399-024-01049-3

Jana Ackmann, Daniel Steven

{"title":"[Conducted energy weapons (CEW)].","authors":"Jana Ackmann, Daniel Steven","doi":"10.1007/s00399-024-01049-3","DOIUrl":"10.1007/s00399-024-01049-3","url":null,"abstract":"Background: Conducted energy weapons (CEW, TASER) are increasingly used by law enforcement agencies in Germany. The CEWs are intended to reduce violence against police officers and to reduce moderate to severe injuries of police officers and aggressors. The delivery of repetitive electrical impulses causes neuromuscular paralysis and incapacitation; however, there are safety concerns due to deaths related to CEWs.Objective: The aim of this article is to provide an overview of the medical risks associated with the use of CEWs.Methods: A literature search was carried out using relevant databases.Results: The CEWs offer a good overall safety profile but in rare cases can have serious or life-threatening health risks. These include injuries to vulnerable body regions and falls. Myocardial capture and malignant arrhythmia can be triggered in animal experiments. The cause of death following the use of a conducted energy device (CED) can often not be clearly attributed due to competing causes; however, in studies with volunteers arrhythmia has not been observed so far. Overall, the risk of life-threatening cardiac arrhythmia in humans appears to be low, although still present. Particularly vulnerable risk groups include children, people with a history of mental illness or with intoxication, pregnant women and cardiac device wearers.Conclusion: Even though in principle CEWs can trigger malignant arrhythmia, the risk is low and the causality of death after CEW deployment often remains unclear. In the medical care of patients after CEW use, comorbidities such as intoxication or mental illness must be considered.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"312-317"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[The 2024 ESC guidelines for management of atrial fibrillation : AF-CARE as new credo]. [2024年ESC心房颤动管理指南：AF-CARE作为新信条]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-13 DOI: 10.1007/s00399-024-01053-7

Julian Wolfes, Lars Eckardt

引用次数: 0

[Left bundle branch pacing is superior to classic cardiac resynchronisation therapy : Pros and cons]. [左束支起搏优于传统的心脏再同步疗法：利弊]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-11-18 DOI: 10.1007/s00399-024-01054-6

Sergio Richter, Bernd Lemke

引用次数: 0

[Epicardial ablation of ventricular tachycardia with cardiac surgery only : Pro/Contra]. [心外膜消融室性心动过速，只需进行心脏手术：赞成/反对]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-02 DOI: 10.1007/s00399-024-01038-6

Christian Sohns, Boris Schmidt

引用次数: 0

[Cardiac arrhythmias in adults with congenital heart disease]. [成人先天性心脏病患者的心律失常]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-12-01 Epub Date: 2024-09-03 DOI: 10.1007/s00399-024-01037-7

Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez

{"title":"[Cardiac arrhythmias in adults with congenital heart disease].","authors":"Katharina Franke, Monika Lüdemann, Maria B Gonzalez Y Gonzalez","doi":"10.1007/s00399-024-01037-7","DOIUrl":"10.1007/s00399-024-01037-7","url":null,"abstract":"In patients with congenital heart disease, cardiac arrhythmias are complex and require a thorough understanding of the anatomy, past surgical and interventional procedures, and the specific electric processes. Supraventricular tachycardias commonly present as emergency situations and should be treated immediately, particularly when there is an underlying complex malformation. Establishing sinus rhythm is usually superior to pure frequency control for hemodynamic reasons. Catheter ablation should be preferred over medical treatment, even though several procedures are often necessary. In addition, bradycardia is seen more frequently in congenital heart defects; this could be aggravated by antiarrhythmic drugs. There are significant differences between the indications and techniques used for pacemaker implantation in patients with congenital heart defects and those without. Patients with complex congenital heart diseases have an increased risk of thromboembolism; therefore, an individual and early indication for low-threshold oral anticoagulation is necessary; direct oral anticoagulants can also be used for this purpose. In risk stratification for sudden cardiac death, the principles of general guidelines are often not applicable, and individualized decisions are required. Recently, a new general risk score for congenital heart disease has been developed. The treatment of cardiac arrhythmias in patients with congenital heart disease should always be performed in close cooperation with specialized centers.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"327-333"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Holter monitoring]. [Holter监测]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-08-19 DOI: 10.1007/s00399-024-01036-8

Carsten W Israel, Sona Tribunyan

引用次数: 0

[The challenge: specialization meets general medicine]. [挑战：专业化与全科医学]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-08-22 DOI: 10.1007/s00399-024-01034-w

Harilaos Bogossian, Sonia Busch

引用次数: 0

Ventricular arrhythmias in the context of chronic kidney disease and electrolyte imbalance. 慢性肾病和电解质失衡导致的室性心律失常。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2024-09-01 Epub Date: 2024-07-15 DOI: 10.1007/s00399-024-01029-7

Ines Masmoudi, Zouhir Dindane, Sergio Richter, Micaela Ebert

引用次数: 0